■本报记者冯梓剑 清晨的薄雾漫过上林县镇圩瑶族乡的山峦，早上8点，蓝惠晓准时来到佛子村卫生室，细细擦拭诊桌， 将血压计、针灸针等一一摆放整齐，静待乡亲们到来。不远处的洋造村卫生室里，妻子石梅林也在整理 着村民的健康档案，将乡亲们的身体状况一一记在心间。寒来暑往，这对村医夫妻，在镇圩瑶族乡的山 村里一守就是29年，他们的脚步，踏遍了乡村每条山路；他们的身影，出现在乡亲们最需要的每个时 刻。 下午6点，夕阳西下，当大多数人结束一天的工作踏上归途时，蓝惠晓的"下半场"才刚刚开始。他带着 医疗包，骑上电动单车，沿着蜿蜒的山路驶向那些患有慢性病、行动不便的村民家中，开启每日的上门 随访。 蓝志生老人因中风行动不便，是蓝惠晓的重点关注对象。刚走到院门口，老人的老伴罗连明就迎了上 来。"蓝医生经常来家里照顾我们，帮我们测量血压，用中医技术调理身体，比我们的孩子还要亲！"老 人说。 对蓝惠晓和石梅林来说，乡村医生没有"下班"的明确界限。29年来，他们的手机从未关过机，无论深夜 还是凌晨，只要村民一个电话，他们就会立刻背起药箱出门。有一次，村里一位老人突发急病，石梅林 接到电话后，冒着大雨摸黑赶路，及时赶到老人家中进行急救，为 ...

（来源：工人日报） "刚进场时，几乎每位同事都有不同程度的高原反应，头痛、气短、失眠是家常便饭。"项目负责人回忆 道。面对海拔高、气温低、氧气稀薄、医疗资源匮乏等多重挑战，项目部迅速组建医务室，在工程全面 推进前，筑牢职工的健康防线。医务室里配备制氧机、血压仪、听诊器、氧气瓶等基础医疗设备，以及 红景天等抗高原反应药品。医务室虽小，却功能齐全，24小时为职工提供医疗咨询、应急救治和健康监 测服务。未来，诺木洪项目部医务室将继续完善高原医疗保障体系，创新服务方式，提升救治能力，为 工程顺利推进、为建设者健康安全保驾护航。 本报讯（记者刘静 通讯员张振宇）在青海省海西州都兰县诺木洪地区，海拔3500米的茫茫戈壁上，中 铁十九局集团轨道公司承建的诺木洪水库配套灌区工程正如火如荼推进。在这个距离都兰县人民医院 207公里、海西州人民医院300多公里的偏远工地，诺木洪项目部医务室默默守护着建设者的健康。 ...

Investment Rating - The report does not explicitly state an investment rating for the medical device industry. Core Insights - The Chinese medical device industry is experiencing rapid growth driven by policy reforms and increasing domestic demand, with a significant rise in the number of production enterprises from 16,356 in 2018 to 36,675 in 2023, reflecting a compound annual growth rate (CAGR) of 17.5% [5][13]. - The market for high-value medical devices (Class III) is expanding, with a notable increase in manufacturers, which grew by 15.5% from 2022 to 2023 [13]. - The medical device market in China is projected to grow from CNY 528.4 billion in 2018 to CNY 1,502.4 billion by 2028, with a CAGR of 14.9% [31]. Summary by Sections Chapter 1: Overview of the Chinese Medical Device Industry - The classification and layout of the medical device industry in China highlight the importance of production capacity and the number of devices held by medical institutions as key indicators of healthcare quality [4][6]. - Recent policy changes have lowered entry barriers for domestic manufacturers and improved the feasibility of remote consultations, enhancing service quality and efficiency [6][9]. Chapter 2: Current Development of the Chinese Medical Device Industry - The industry has undergone a period of contraction followed by recovery and stabilization, with significant regulatory changes promoting innovation and improving the quality and safety of domestic products [16][18]. - The number of registered medical devices has increased, with a shift towards innovative products, particularly in high-value categories [20][24]. Chapter 3: Analysis of the Overseas Expansion of Chinese Medical Devices - The export value of Chinese medical devices surged from CNY 162.2 billion in 2018 to CNY 807.6 billion in 2020, reflecting a CAGR of 123.1% [37]. - In 2023, the export of medical consumables surpassed diagnostic equipment, accounting for 44.9% of total exports, driven by competitive pricing and innovation [37][38]. Chapter 4: Frontier Development Trends in the Chinese Medical Device Industry - The integration of AI in medical devices is gaining momentum, with the Chinese government supporting digital healthcare initiatives to enhance local capabilities and reduce the gap with international standards [46][49]. - The report indicates a growing trend in the adoption of AI technologies in imaging devices, with a significant portion of approvals for AI medical devices in the imaging sector [51].

Core Viewpoint - The company, Jiangsu Lude Medical Electronics Co., Ltd., reported a revenue increase of 4.66% in 2024, but experienced a decline in net profit by 13.08%, indicating challenges in profitability despite revenue growth [1][2]. Financial Performance - The company achieved operating revenue of 344.60 million in 2024, up from 329.26 million in 2023, reflecting a growth of 4.66% [1][2]. - The net profit attributable to shareholders was 27.54 million, down 13.08% from 31.69 million in the previous year [1][2]. - The net profit after deducting non-recurring gains and losses was 26.21 million, a decrease of 12.64% compared to 30.00 million in 2023 [1][2]. - The weighted average return on equity based on net profit attributable to shareholders was 7.00%, down from 8.19% in 2023 [1]. - Basic earnings per share decreased to 0.16 from 0.18, reflecting a decline of 13.08% [1]. Business Overview - Jiangsu Lude Medical focuses on the research, development, production, and sales of home medical devices and healthcare products [5]. - The company has been listed on the Beijing Stock Exchange since November 15, 2021, after being one of the first 32 companies to go public on the selected tier [5]. - The main product categories include home medical devices such as blood pressure monitors, nebulizers, and thermometers, as well as healthcare products related to family health management [6]. Cash Flow and Assets - The net cash flow from operating activities was 13.03 million, showing a significant decline of 61.70% year-on-year [5]. - As of the end of 2024, total assets amounted to 530 million, an increase of 7.94% compared to the previous year [5]. - The equity attributable to shareholders was 400 million, reflecting a growth of 2.61% [5]. Research and Development - The company continued to invest in research and development, with R&D expenses increasing by 4.33% in 2024, aimed at product innovation and technological upgrades [5]. Market Expansion - The company actively expanded its overseas market presence, achieving significant sales growth through cross-border e-commerce platforms [5]. - In 2024, several products received EU MDR CE certification and MDSAP certification, enhancing competitiveness in international markets [5].